A carregar...

Exenatide Effects on Cardiometabolic Risk and Weight in Adolescents with Morbid Obesity and Type 2 Diabetes Mellitus: Two Case Reports

OBJECTIVE: Glucagon-like peptide-1 (GLP-1) receptor agonists improve glycemic control and cardiometabolic risk factors in adults with type 2 diabetes mellitus, but pediatric data is sparse. RESEARCH DESIGN AND METHODS: This is the first report to describe the effects of GLP-1 receptor agonist Exenat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Obes Weight Loss Medicat
Main Authors: Censani, Marisa, Chin, Vivian L, Fennoy, Ilene
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4864000/
https://ncbi.nlm.nih.gov/pubmed/27182560
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!